Sunho (China) Biopharmaceutical Co., Ltd.

founded in 2018, sunho is an innovative biologics r&d and manufacturing company focusing on antibody and cytokines with a deep understanding on immune microenvironment. we hope to provide patients with more effective treatment options and meet more clinical needs through innovative target, molecular conformation and moa design. currently, sunho has 4 ind approvals and are in phase i clinical trials in china, including 2 projects that have been approved by both fda and nmpa. more than 10 projects are in different stages of preclinical development, with excellent therapeutic efficacy observed in animal models. in order to better develop the projects, we hope to collaborate with excellent pharmaceutical companies to accelerate the progress of clinical trials around the world, so that we could benefit the patients more quickly. you can send e-mail to chenzi@sunho-bio.com to inquire more info. thank you!